Cardiorespiratory Rehabilitation

Cardiorespiratory Rehabilitation

Rehabilitation is structured, supervised exercise combined with education and behaviour change. It is one of the most effective treatments in all of respiratory and cardiac medicine — improving how far and how comfortably people can move, their quality of life, and their risk of hospital admission — yet it remains under-used.¹

Pulmonary rehabilitation

Pulmonary rehabilitation is for people with chronic lung disease — COPD, bronchiectasis, interstitial lung disease such as IPF, and persistent symptoms after COVID-19. A typical programme runs for around 8 weeks with two supervised sessions a week, combining individually-prescribed aerobic training (walking or cycling), resistance training, and education on the condition, medicines, breathing strategies and self-management.² The benefits — greater exercise capacity, less breathlessness, better quality of life and fewer hospital admissions — are well established, and referral soon after a flare-up is particularly valuable.³

Cardiac rehabilitation

Cardiac rehabilitation is for people with established cardiovascular disease — after a heart attack, after stent or bypass surgery, with heart failure, or after valve surgery. Alongside supervised exercise it addresses risk factors (blood pressure, lipids, smoking, weight, diabetes), psychological wellbeing and education. It improves functional capacity and, importantly, reduces hospital readmission and cardiovascular mortality.⁴ Programmes move through an early supervised phase to a long-term maintenance phase the patient continues independently.⁵

The Inspire Clinic hybrid cardiorespiratory programme

Many of our patients have both heart and lung disease — heart failure alongside COPD, for example — and fall between the cracks of single-system programmes. Inspire Clinic runs an integrated hybrid cardiorespiratory rehabilitation programme that brings the exercise prescription, monitoring and education of both pulmonary and cardiac rehabilitation into one individualised pathway. It blends individually-prescribed aerobic and resistance training with airway clearance and breathing strategies where needed, inspiratory muscle training, and disease-specific education — delivered as supervised individual or small-group sessions, with home-based and remotely-monitored options. This avoids duplicated, fragmented care and treats the person rather than a single organ.

Is it safe?

Supervised rehabilitation is safe even in advanced disease; exercise is titrated to symptoms and monitored throughout. We screen for the small number of situations — such as unstable angina, decompensated heart failure or severe aortic stenosis — where exercise must be modified or deferred until the condition is stabilised.

References & evidence base

1. Spruit MA, Singh SJ, Garvey C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med 2013;188(8):e13–e64.
2. Holland AE, Cox NS, Houchen-Wolloff L, et al. Defining modern pulmonary rehabilitation: an official American Thoracic Society workshop report. Ann Am Thorac Soc 2021;18(5):e12–e29.
3. McCarthy B, Casey D, Devane D, et al. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2015;(2):CD003793.
4. Anderson L, Thompson DR, Oldridge N, et al. Exercise-based cardiac rehabilitation for coronary heart disease. Cochrane Database Syst Rev 2016;(1):CD001800.
5. Taylor RS, Dalal HM, McDonagh STJ. The role of cardiac rehabilitation in improving cardiovascular outcomes. Nat Rev Cardiol 2022;19(3):180–194.

References are numbered in citation order (Vancouver/BMJ style) and were current at the time of writing. Guidelines are living documents — verify against the latest version before clinical use.